Manufacturing: Page 51
-
NICE: More novel anticoagulant use could reduce strokes
The British agency has recommended adding novel anticoagulants to formularies throughout the UK.
By Nicole Gray • June 18, 2014 -
Pfizer, Novartis push for approval of meningitis vaccines
The two companies each have developed a vaccine to prevent a virulent form of meningitis.
By Nicole Gray • June 18, 2014 -
Pfizer expands research capacity with Cambridge, MA location
The firm is setting up a mega-research facility, bringing together industry, academic and the hospital system to collaborate on therapeutic innovation.
By Nicole Gray • June 18, 2014 -
Teva closing manufacturing sites to cut costs
As part of broader cost-cutting and streamlining measures, the company will close half of its manufacturing sites.
By Nicole Gray • June 18, 2014 -
Sanofi, Medtronic team up to offer options for diabetes patients
The new partnership focuses on innovative drug-device breakthroughs.
By Nicole Gray • June 17, 2014 -
Insulin 300 performs well in phase III trials
Will it beat its competitors?
By Nicole Gray • June 17, 2014 -
Deep Dive
As diabetes soars, so do research and treatment options
Currently, about 180 drugs are in development to address the diabetes-related challenges that persist despite available treatments.
By Nicole Gray • June 16, 2014 -
Medtronic buying Ireland-based Covidien
The merger will make Medtronic a mega-medical-device company.
By Nicole Gray • June 16, 2014 -
Parion, Santen bring dry eye drug to Asian markets
The drug has a novel mode of action and will help Parion build an Asian distribution network with a new partner.
By Nicole Gray • June 13, 2014 -
Deep Dive
Small companies may be key to big advances in malaria treatment
Malaria remains a major killer worldwide, and treatments quickly become ineffective because of resistance. On an industry level, smaller firms are taking on that challenge.
By Nicole Gray • June 13, 2014 -
Protein Sciences boosts influenza vaccine availability, distribution
In response to healthcare professionals who want access to Flublok ahead of the 2014-15 flu season, the company will make its recombinant vaccine available as early as September.
By Nicole Gray • June 13, 2014 -
Pharma leaders at Biovision discuss high costs of innovation
Executives from Sanofi and Johnson & Johnson discussed the underlying reasons that the cost of drug development, and by extension drug prices, seem high.
By Nicole Gray • June 10, 2014 -
GelStat gets medical marijuana foothold with Mastix Medica acquisition
The acquisition will bolster Gelstat's weight-loss chewing gum product line and allow the company to move into the high CBD/low THC market.
By Nicole Gray • June 10, 2014 -
Pfenex uses R&D prowess to develop AMD alternative to Lucentis
The company has brought its AMD candidate into clinical trials in just two years---and based on its high-throughput screening technology, there are many more candidate-concepts ready to be hatched.
By Nicole Gray • June 9, 2014 -
Frontage Labs to expand key facilities
The company will expand manufacturing, research and office-based facilities. Its role helping pharmaceutical companies advance research and development efforts is in high demand---and growing.
By Nicole Gray • June 5, 2014 -
Bayer, Orion partnering to develop prostate cancer drug
Bayer is trying to build a strong portfolio in this therapeutic area--and is off to a good start with Xofigo, which was approved last year.
By Nicole Gray • June 5, 2014 -
Deep Dive
India battles quality issues as generic drug demand rises
Headlines announcing a recall of drugs manufactured in India are commonplace, but the FDA intends to change that -- with support from Indian authorities.
By Nicole Gray • June 4, 2014 -
Century-old testing procedure about to change
Researchers increasingly use genomics to guide their research, but active pharmaceutical ingredient testing is based on technology developed 100 years ago. That will be overhauled in 2015.
By Nicole Gray • June 4, 2014 -
Generic celecoxib approved in the US
Despite the black box warning on Celebrex (celecoxib), many patients find relief from arthritis and orthopedic pain with the drug. Recent FDA approval of generic celecoxib will now make that therapeutic relief less costly.
By Nicole Gray • June 2, 2014 -
Report analyzes pros, cons of clinical research in 'BRIC' countries
The countries -- Brazil, Russia, India and China -- represent an opportunity for conducting clinical trials, Thomson Reuters reports. There are 30 million potential subjects, access to lab settings and well-educated healthcare professionals and manufacturing capabilities. But there are also challenges.
By Nicole Gray • May 29, 2014 -
Top analyst ranks 22 pharma firms based on R&D prowess
Bristol-Myers Squibb tops the list, compiled by analyst Richard Evans.
By Nicole Gray • May 27, 2014 -
Growing fear of MERS virus increases urgency of researchers
MERS has killed 181 people worldwide, but its appearance in the U.S. this month surprised authorities. Researchers at NovaVax are using a new method to develop vaccines, which could decrease the decade-long timeline and $1 billion cost associated with vaccine development.
By Nicole Gray • May 22, 2014 -
Roche expands manufacturing capacity as biologics revenues grow
Roche's oncology franchise continues to grow, with rapidly increasing revenues. To keep up with demand, the company is investing more than $1 billion in increasing manufacturing capacity, with the majority of the investment aimed at biologics manufacturing.
By Nicole Gray • May 19, 2014 -
Abbott seals deal to buy South American pharma company
Abbott is buying CFR Pharmaceuticals in Chile, with the goal of growing its portfolio, capacity and growth rate.
By Nicole Gray • May 19, 2014 -
Sun Pharma faces another massive drug recall
The company now has recalled three drugs in three months.
By Nicole Gray • May 16, 2014
Previous
To find more content, use the "Topics" in the menu above.
